HC
Highmount Capital Portfolio holdings
AUM
$391M
Turnover
10.22%
1-Year Est. Return
2.65%
This Fund
S&P 500
This Quarter
Est. Return
-2.01%
1 Year Est. Return
+2.65%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$391M
AUM Growth
-$21.5M
(-5.2%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
45.77%
Holding
137
New
5
Increased
45
Reduced
46
Closed
9
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$3.54M |
| 2 |
AbbVie
ABBV
|
+$3.12M |
| 3 |
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
|
+$2.79M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.29M |
| 5 |
Wynn Resorts
WYNN
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$17.3M |
| 2 |
Travel + Leisure Co
TNL
|
+$3.61M |
| 3 |
MON
Monsanto Co
MON
|
+$2.1M |
| 4 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$1.97M |
| 5 |
Camden Property Trust
CPT
|
+$991K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.1% |
| 2 | Financials | 9.25% |
| 3 | Healthcare | 7.72% |
| 4 | Technology | 7.71% |
| 5 | Industrials | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CELG
76
DELISTED
Celgene Corp
CELG
| $991K | 0.25% |
8,565
+65
| +0.8% | +$7.43K |
2013 Q2
8 quarters
|
|
77
Invesco Water Resources ETF
PHO
$1.93B
| $942K | 0.24% |
37,750
-850
| -2% | -$21.6K |
2013 Q2
8 quarters
|
|
78
Coca-Cola
KO
$395B
| $893K | 0.23% |
22,751
-850
| -4% | -$34.6K |
2013 Q2
8 quarters
|
|
79
VanEck Agribusiness ETF
MOO
$1.14B
| $886K | 0.23% |
16,075
| – | – |
2013 Q2
8 quarters
|
|
80
Barings BDC
BBDC
$886M
| $831K | 0.21% |
35,440
-2,510
| -7% | -$59.5K |
2013 Q2
8 quarters
|
|
81
Goldman Sachs
GS
$256B
| $787K | 0.2% |
3,771
| – | – |
2013 Q2
8 quarters
|
|
82
Capital Southwest
CSWC
$1.49B
| $731K | 0.19% |
39,901
| – | – |
2013 Q2
8 quarters
|
|
83
Target
TGT
$70.6B
| $689K | 0.18% |
8,445
-5,183
| -38% | -$419K |
2013 Q2
8 quarters
|
|
84
Qualcomm
QCOM
$184B
| $666K | 0.17% |
10,640
-385
| -3% | -$26.3K |
2013 Q2
8 quarters
|
|
85
Invesco MSCI Sustainable Future ETF
ERTH
$120M
| $635K | 0.16% |
20,850
| – | – |
2013 Q2
8 quarters
|
|
86
Invesco
IVZ
$12.3B
| $584K | 0.15% |
15,585
-5,180
| -25% | -$207K |
2013 Q2
8 quarters
|
|
87
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
| $573K | 0.15% |
5,355
+3,450
| +181% | +$373K |
2014 Q4
2 quarters
|
|
88
Illinois Tool Works
ITW
$76.7B
| $555K | 0.14% |
6,045
| – | – |
2013 Q2
8 quarters
|
|
89
DELISTED
Walgreens Boots Alliance
WBA
| $553K | 0.14% |
6,550
| – | – |
2013 Q2
8 quarters
|
|
90
CVS Health
CVS
$116B
| $551K | 0.14% |
5,250
| – | – |
2013 Q2
8 quarters
|
|
|
ESRX
91
DELISTED
Express Scripts Holding Company
ESRX
| $541K | 0.14% |
6,086
| – | – |
2013 Q2
8 quarters
|
|
92
Merck
MRK
$364B
| $537K | 0.14% |
9,885
| – | – |
2013 Q2
8 quarters
|
|
93
iShares Russell 2000 Growth ETF
IWO
$13.5B
| $533K | 0.14% |
3,450
+20
| +0.6% | +$3.06K |
2013 Q2
8 quarters
|
|
|
XBKS
94
DELISTED
XENITH BANKSHARES INC , COMMON STOCK
XBKS
| $523K | 0.13% |
87,000
| – | – |
2013 Q2
8 quarters
|
|
95
AT&T
T
$158B
| $517K | 0.13% |
19,336
-4,938
| -20% | -$128K |
2013 Q2
8 quarters
|
|
96
DELISTED
Anadarko Petroleum
APC
| $514K | 0.13% |
6,590
| – | – |
2013 Q2
8 quarters
|
|
97
Gilead Sciences
GILD
$190B
| $492K | 0.13% |
4,200
| – | – |
2013 Q2
8 quarters
|
|
98
Verizon
VZ
$185B
| $478K | 0.12% |
10,262
-122
| -1% | -$5.97K |
2013 Q2
8 quarters
|
|
|
99
Camden Property Trust
CPT
$11.3B
| $468K | 0.12% |
6,298
-13,090
| -68% | -$991K |
2013 Q2
8 quarters
|
|
|
CMCSK
100
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $453K | 0.12% |
7,550
| – | – |
2013 Q2
8 quarters
|
|
Similar funds
GMCM
STI
RRC
CG
SCVF
F
R
SBK
Highmount Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Highmount Capital held 137 positions worth $391M, down 5.2% from $412M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Highmount Capital withdrew a net $12.2M in Q2 2015, closing 9 positions and reducing 46 holdings. Its most notable exit was WisdomTree Europe Hedged Equity Fund, an estimated $17.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 56% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Highmount Capital opened a new position in Capri Holdings worth $2.64M.
- Highmount Capital's largest Q2 2015 buy was Capri Holdings: 62,745 shares worth $2.64M.
- Highmount Capital added most to AbbVie in Q2 2015, an estimated $3.12M increase.
- Highmount Capital's biggest Q2 2015 reduction was Monsanto Co, cutting an estimated $2.1M.
- Highmount Capital fully exited WisdomTree Europe Hedged Equity Fund in Q2 2015, selling an estimated $17.3M.
- Highmount Capital's ten largest holdings make up 46% of its $391M portfolio in Q2 2015.
- Highmount Capital opened 5 new positions and closed 9 in Q2 2015.
- Highmount Capital's portfolio value fell 5.2% quarter-over-quarter to $391M.
Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.